Your browser doesn't support javascript.
loading
Los inhibidores SGLT2: una mirada al futuro del tratamiento de la insuficiencia cardiaca / Sodium-glucose cotransporter 2 inhibitors for the management of heart failure
Nouel, Ana; Winter, José Luis; Sepúlveda, Luis.
  • Nouel, Ana; Clínica Alemana de Santiago. Departamento de Enfermedades Cardiovasculares. Santiago. CL
  • Winter, José Luis; Clínica Alemana de Santiago. Departamento de Enfermedades Cardiovasculares. Santiago. CL
  • Sepúlveda, Luis; Clínica Alemana de Santiago. Departamento de Enfermedades Cardiovasculares. Santiago. CL
Rev. méd. Chile ; 150(12): 1647-1654, dic. 2022. ilus, tab
Article in Spanish | LILACS | ID: biblio-1515395
ABSTRACT
Heart failure (HF) is a global health problem. There is a strong association h between HF and type 2 diabetes mellitus (DM2), with an increasing prevalence of patients having both conditions concomitantly. Sodium-glucose cotransporter 2 inhibitors (ISGLT2) significantly reduce cardiovascular events, including cardiovascular death. In this article we will focus on the current evidence about the effectiveness of these medications in adults with heart failure with reduced or preserved ejection fraction.
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors / Heart Failure Limits: Humans Language: Spanish Journal: Rev. méd. Chile Journal subject: Medicine Year: 2022 Type: Article Affiliation country: Chile Institution/Affiliation country: Clínica Alemana de Santiago/CL

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors / Heart Failure Limits: Humans Language: Spanish Journal: Rev. méd. Chile Journal subject: Medicine Year: 2022 Type: Article Affiliation country: Chile Institution/Affiliation country: Clínica Alemana de Santiago/CL